Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Blood groups associated with risk of heart attack

    Author:
    HT Staff
    Publish date: May 2, 2017

    PARIS—Having a blood type other than O is associated with a higher risk of heart attack, according to a meta-analysis. “It has been suggested...

    • Read More

    News

    Drug receives orphan designation for AML

    Author:
    HT Staff
    Publish date: May 2, 2017

    The US Food and Drug Administration (FDA) has granted orphan drug designation for PTX-200 for the treatment of acute myeloid leukemia (AML). PTX-...

    • Read More

    News

    Simplifying consent forms doesn’t affect patient comprehension

    Author:
    HT Staff
    Publish date: May 2, 2017

    Simplifying consent documents does not affect how well potential participants understand a clinical trial, according to new research. The study...

    • Read More

    News

    FDA approves midostaurin to treat FLT3+ AML, advanced SM

    Author:
    HT Staff
    Publish date: May 1, 2017

    The US Food and Drug Administration (FDA) has granted approval for the oral, multi-targeted kinase inhibitor midostaurin (Rydapt). The drug is...

    • Read More

    News

    FDA approves test to detect FLT3 mutations

    Author:
    HT Staff
    Publish date: May 1, 2017

    The US Food and Drug Administration (FDA) has approved use of the LeukoStrat® CDx FLT3 Mutation Assay as a companion diagnostic test. The...

    • Read More

    News

    Pembrolizumab could change treatment paradigm, team says

    Author:
    HT Staff
    Publish date: April 30, 2017

    The anti-PD-1 therapy pembrolizumab could change the treatment paradigm of relapsed or refractory classic Hodgkin lymphoma (cHL), according to...

    • Read More

    News

    EC expands approval for daratumumab in MM

    Author:
    HT Staff
    Publish date: April 29, 2017

    The European Commission (EC) has expanded the approved use of the anti-CD38 antibody daratumumab (Darzalex®). Daratumumab is now approved for use...

    • Read More

    News

    Scientists create online database to aid CML research

    Author:
    HT Staff
    Publish date: April 28, 2017

    A newly launched online database provides researchers with access to data on gene expression in chronic myeloid leukemia (CML). The LEUKomics...

    • Read More

    News

    England did not benefit from CDF, analysis suggests

    Author:
    HT Staff
    Publish date: April 28, 2017

    The National Health Service’s (NHS) Cancer Drugs Fund (CDF) has not benefitted the people of England and may have been detrimental for English...

    • Read More

    News

    EMA recommends orphan status for drug for DLBCL

    Author:
    HT Staff
    Publish date: April 28, 2017

    The European Medicines Agency (EMA) has recommended that PQR309 receive orphan drug designation for the treatment of patients with diffuse large B...

    • Read More

    News

    How choline increases the risk of thrombotic events

    Author:
    HT Staff
    Publish date: April 28, 2017

    Past research indicated that choline, a nutrient found in animal products, is associated with a heightened risk of thrombosis. Now, researchers...

    • Read More

    News

    Fertility treatments linked to risk of pediatric cancers

    Author:
    HT Staff
    Publish date: April 27, 2017

    Children born to mothers who underwent fertility treatments have an increased risk of developing pediatric neoplasms, according to research...

    • Read More

    News

    TXA lowers risk of death from post-partum hemorrhage

    Author:
    HT Staff
    Publish date: April 27, 2017

    Treatment with tranexamic acid (TXA) should become the frontline response to major bleeding after childbirth, according to researchers. Results...

    • Read More

    News

    Program allows select Europeans access to belinostat

    Author:
    HT Staff
    Publish date: April 27, 2017

    A managed access program is making the histone deacetylase inhibitor belinostat (Beleodaq®) available to patients in Europe who have relapsed or...

    • Read More

    News

    DLA tablets cure drug-resistant malaria

    Author:
    HT Staff
    Publish date: April 27, 2017

    Researchers have reported that tablets made from dried leaves of the Artemisia annua plant were able to cure malaria in 18 critically ill patients...

    • Read More

    Pages

    • « first
    • …
    • 62
    • 63
    • 64
    • 65
    • 66
    • 67
    • 68
    • 69
    • 70
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery